Efficacy Study of Nifedipine Controlled-Release Tablets (Xin Ran) to Treat Mild to Moderate Essential Hypertension
Status:
Completed
Trial end date:
2014-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare nifedipine controlled-release (CR) tablets (Xin Ran)
with nifedipine controlled-release tablets (Adalat）in the treatment of mild to moderate
essential hypertension.